Redwire Space: Lunar Dominance, Microgravity Drugs, and Extraterrestrial Life with CEO Peter Cannito

Redwire Space CEO

The player is loading ...

Show Notes

In this episode of After Earnings, hosts Katie Perry and Austin Hankwitz sit with Peter Cannito, CEO of Redwire, to talk about their strategic positioning and potential impact on the space industry. Peter breaks down the company's role in driving growth and innovation through partnerships like Eli Lilly for microgravity drug research, as well as the bidding process, security clearances, and the importance of space exploration.

$RDW

TIMESTAMPS:

00:00:00 START

00:03:02 Where Redwire lies in the space value chain

00:06:06 Redwire’s Q4 national security revenue

00:10:23 On space race and moon dominance

00:15:01 The outlook for drug development in space

00:24:52 Drivers for profitable growth rate

00:31:17 The dynamics of space industry revenues

00:35:09 The bidding process

00:48:08 Aliens: Are they real or not real?

After Earnings is brought to you by Stakeholder Labs and Morning Brew.